의약품 위탁 포장 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Pharmaceutical Contract Packaging Market was valued at USD 17.1 billion in 2024 and is estimated to grow at a CAGR of 7.8% to reach USD 35.9 billion by 2034. Rapid transformations across the pharmaceutical sector are significantly influencing the way medications are packaged and delivered. With rising demand for personalized therapies and advancements in biotech innovation, pharmaceutical manufacturers are increasingly turning to specialized contract packaging providers to address evolving needs. As drug development becomes more targeted and small-batch production gains traction, packaging solutions must be agile, compliant, and capable of handling diverse dosage forms and sensitive formulations.

Contract packaging partners are playing a pivotal role by offering scalable services that align with shifting regulatory frameworks, heightened traceability demands, and growing patient-centric care models. The expanding global footprint of pharmaceutical production and distribution further underscores the need for streamlined packaging processes that ensure security, quality, and regulatory alignment across international markets. Digital transformation, coupled with automation and smart packaging tools, is elevating efficiency while reinforcing safety throughout the supply chain. As sustainability becomes a major priority, companies are also integrating eco-conscious materials to reduce environmental impact without compromising performance.

The secondary packaging segment is anticipated to witness substantial growth, with expectations to reach USD 14.3 billion by 2034. Serialization mandates, tamper-proof features, and informative labeling are fueling the rise in demand for advanced secondary packaging services. Smart packaging formats are becoming a preferred choice, especially for prescription and over-the-counter medications, as they enable real-time verification and enhanced patient engagement through QR codes and digital interfaces. In line with global green packaging initiatives, recycled cartonboard, eco-friendly inks, and water-based coatings are gaining traction, especially in secondary packaging applications designed for improved sustainability and end-user accessibility.

The plastic segment in the pharmaceutical contract packaging space is projected to generate USD 10 billion by 2034. Known for its cost efficiency and excellent barrier properties, plastic remains a dominant material across a wide range of drug formulations. However, increasing environmental concerns are steering the market toward biodegradable and recyclable plastics. In response, contract packaging providers are developing next-generation plastic solutions, such as lightweight bio-based materials and high-barrier bioplastics that maintain product integrity while supporting sustainability goals.

United States Pharmaceutical Contract Packaging Market generated USD 5.3 billion in 2024, driven by stringent regulatory standards and evolving serialization requirements. The implementation of the Drug Supply Chain Security Act (DSCSA) has encouraged unit-level traceability, blockchain integration, and automation of smart labeling technologies. Growth in biologics, gene and cell therapies, and temperature-sensitive drugs is pushing service providers to enhance cold chain packaging infrastructure to meet demand.

Notable players in the Global Pharmaceutical Contract Packaging Market include Ameripac, Amcor, Baxter Biopharma Solutions, Adare Pharma Solutions, and Catalent Pharma Solutions. Companies are leveraging automation, serialization, and smart packaging technologies such as NFC and QR to improve compliance, traceability, and user interaction. Early-stage collaboration with pharmaceutical developers and an emphasis on sustainable materials are helping contract packagers deliver customized, future-ready packaging solutions.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing pharmaceutical industry
    • 3.2.1.2 Growing demand for biotechnology and specialty drugs
    • 3.2.1.3 Increase in clinical trials & small-batch packaging
    • 3.2.1.4 Increasing demand for sustainable packaging
    • 3.2.1.5 Increased focus on serialization & anti-counterfeiting
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High initial investment & operational costs
    • 3.2.2.2 Intense competition & price pressure
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Gap analysis
• 3.8 Porter’s analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates & Forecast, By Type, 2021-2034 (USD Billion)

• 5.1 Key trends
• 5.2 Primary packaging
  • 5.2.1 Bottles & jars
  • 5.2.2 Vials
  • 5.2.3 Ampoules
  • 5.2.4 Blister packs
  • 5.2.5 Prefilled syringes
  • 5.2.6 Others
• 5.3 Secondary packaging
• 5.4 Tertiary packaging

Chapter 6 Market Estimates & Forecast, By Material, 2021-2034 (USD Billion)

• 6.1 Key trends
• 6.2 Plastic
• 6.3 Glass
• 6.4 Paper & paperboard
• 6.5 Aluminium
• 6.6 Others

Chapter 7 Market Estimates & Forecast, By Form Type, 2021-2034 (USD Billion)

• 7.1 Key trends
• 7.2 Oral
• 7.3 Injectable
• 7.4 Others

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 (USD Billion)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Adare Pharma Solutions
• 9.2 Amcor
• 9.3 Ameripac
• 9.4 Baxter Biopharma Solutions
• 9.5 Catalent Pharma Solutions
• 9.6 Daito Pharmaceutical
• 9.7 Gracure Pharmaceutical
• 9.8 MJS Packaging
• 9.9 Nipro
• 9.10 Patheon
• 9.11 Pharma Packaging Solutions
• 9.12 Schott
• 9.13 Sharp
• 9.14 Sonic Packaging Industries
• 9.15 West Pharmaceutical Services
• 9.16 WestRock
• 9.17 Zoic Biotech